FR2190454B1 - - Google Patents

Info

Publication number
FR2190454B1
FR2190454B1 FR7323703A FR7323703A FR2190454B1 FR 2190454 B1 FR2190454 B1 FR 2190454B1 FR 7323703 A FR7323703 A FR 7323703A FR 7323703 A FR7323703 A FR 7323703A FR 2190454 B1 FR2190454 B1 FR 2190454B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7323703A
Other versions
FR2190454A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU65622A external-priority patent/LU65622A1/xx
Priority claimed from LU65621A external-priority patent/LU65621A1/xx
Application filed by LOreal SA filed Critical LOreal SA
Publication of FR2190454A1 publication Critical patent/FR2190454A1/fr
Application granted granted Critical
Publication of FR2190454B1 publication Critical patent/FR2190454B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/281-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F18/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid
    • C08F18/02Esters of monocarboxylic acids
    • C08F18/04Vinyl esters
    • C08F18/10Vinyl esters of monocarboxylic acids containing three or more carbon atoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7323703A 1972-06-29 1973-06-28 Expired FR2190454B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU65622A LU65622A1 (fr) 1972-06-29 1972-06-29
LU65621A LU65621A1 (fr) 1972-06-29 1972-06-29

Publications (2)

Publication Number Publication Date
FR2190454A1 FR2190454A1 (fr) 1974-02-01
FR2190454B1 true FR2190454B1 (fr) 1976-12-31

Family

ID=26640110

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7323703A Expired FR2190454B1 (fr) 1972-06-29 1973-06-28

Country Status (11)

Country Link
US (1) US3946035A (fr)
JP (1) JPS5415705B2 (fr)
AT (1) AT336269B (fr)
CA (1) CA1027293A (fr)
CH (2) CH578021A5 (fr)
DE (1) DE2333211A1 (fr)
ES (2) ES416403A1 (fr)
FR (1) FR2190454B1 (fr)
GB (1) GB1442640A (fr)
NL (1) NL7309151A (fr)
SE (2) SE419992B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107290A (en) * 1972-06-29 1978-08-15 L'oreal Anti-solar polymers, method of making the same and cosmetic compositions containing the same
JPS55500053A (fr) * 1978-01-16 1980-01-31
US4701521A (en) * 1978-07-17 1987-10-20 The Trustees Of Boston University Method of effecting cellular uptake of molecules
FR2629084B1 (fr) * 1988-03-28 1990-11-30 Essilor Int Polymeres supports de produits actifs relargables, de type hydrogel, compositions correspondantes et leur procede de preparation
US5753246A (en) * 1995-11-20 1998-05-19 Peters; Marlin W. Packaged germicidal towelette, sanitation kit and method for promoting hygiene
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
EP1372675A2 (fr) * 2001-01-18 2004-01-02 Geltex Pharmaceuticals, Inc. Polymeres d'ionene et leur utilisation en tant qu'agents antimicrobiens
EP1436006A4 (fr) * 2001-10-16 2006-06-07 Avanir Pharmaceuticals Inhibition virale par n-docosanol
AU2003291087A1 (en) * 2002-11-19 2004-06-15 Genzyme Corporation Ionene oligomers and polymers
WO2012134965A1 (fr) * 2011-03-25 2012-10-04 The Trustees Of Columbia University In The City Of New York Modulateurs de canaux chlorure et de transporteurs de chlorure pour thérapie dans les maladies des muscles lisses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2888380A (en) * 1954-11-05 1959-05-26 Merck & Co Inc S-ethyl cysteine compositions for combatting tubercle bacilli
FR92221E (fr) * 1965-03-03 1968-10-11 Oreal Nouveaux copolymères et applications de ces copolymères à la cosmétique
LU54202A1 (fr) * 1967-07-28 1969-03-24 Oreal Procédé de préparation de nouveaux copolymères et compositions cosmétiques contenant ces copolymères
US3535337A (en) * 1967-07-26 1970-10-20 Merck & Co Inc 1-p-chlorobenzoyl-2-methyl-3-metallo-methyl indoles
US3798235A (en) * 1967-12-09 1974-03-19 Sumitomo Chemical Co Novel method for producing 1-phenyl-3-indolylacetic acid derivatives
DE1930306A1 (de) * 1968-06-18 1970-01-02 Colgate Palmolive Co Substantive Lichtschutzmittel

Also Published As

Publication number Publication date
DE2333211C2 (fr) 1988-09-08
CH579599A5 (fr) 1976-09-15
CA1027293A (fr) 1978-02-28
NL7309151A (fr) 1974-01-02
ATA578673A (de) 1976-08-15
AT336269B (de) 1977-04-25
CH578021A5 (fr) 1976-07-30
JPS4958195A (fr) 1974-06-05
ES416403A1 (es) 1976-07-01
ES442306A1 (es) 1977-10-01
GB1442640A (en) 1976-07-14
DE2333211A1 (de) 1974-04-04
SE7708537L (sv) 1977-07-25
JPS5415705B2 (fr) 1979-06-16
US3946035A (en) 1976-03-23
SE419992B (sv) 1981-09-07
AU5763373A (en) 1975-01-09
FR2190454A1 (fr) 1974-02-01

Similar Documents

Publication Publication Date Title
AU465353B2 (fr)
FR2193574A1 (fr)
JPS4982740A (fr)
FR2190454B1 (fr)
FR2202733B1 (fr)
FR2178140B3 (fr)
JPS4925875A (fr)
FR2172327A1 (fr)
JPS4965677A (fr)
JPS4948782A (fr)
FR2204868A1 (fr)
JPS4976035A (fr)
JPS5022869Y2 (fr)
JPS5228504Y2 (fr)
JPS5333942B2 (fr)
JPS49102927U (fr)
JPS4910994U (fr)
CS152722B1 (fr)
CS152733B1 (fr)
CS152982B2 (fr)
AU4040772A (fr)
JPS4895254U (fr)
BE787388A (fr)
CH559905A5 (fr)
CH559392A5 (fr)